HLA class II specificities in vasculitis with antibodies to neutrophil cytoplasmic antigens

Kidney Int. 1992 Apr;41(4):1059-63. doi: 10.1038/ki.1992.161.

Abstract

HLA class II genes were examined in patients with small vessel vasculitis associated with anti-neutrophil cytoplasmic antibodies (ANCA) using restriction fragment length polymorphism and allele specific oligonucleotide typing. Fifty-nine patients were studied, 34 with Wegener's granulomatosis and 25 with microscopic polyarteritis, and their results were compared with those from 1103 British Caucasoid controls. The frequency of HLA-DQw7 was significantly increased in patients with vasculitis (patients 53%; controls 27.8%, chi 2 17.8, Pc less than 0.0025, relative risk 2.9), and all the DQw7 bearing haplotypes commonly found in Caucasoid populations contributed to the increase. By contrast, the frequency of HLA-DR3 bearing haplotypes was decreased in the patients (patients 6.8%; controls 21.6%, chi 2 6.7, P less than 0.01). HLA specificities were similar in the groups of patients presenting with Wegener's granulomatosis and microscopic polyarteritis and with different types of ANCA assessed by indirect immunofluorescence. However, patients with the DQw7, DR4 haplotype were significantly more likely to have transiently positive tests for ANCA than patients with other DQw7 bearing haplotypes, whereas patients with DR2 bearing haplotypes were more likely to have persistently positive ANCA. These results show that HLA class II genes are associated with small vessel vasculitis and may influence the duration of the associated autoimmune response.

MeSH terms

  • Antibodies, Antineutrophil Cytoplasmic
  • Antibody Specificity
  • Autoantibodies / analysis*
  • Base Sequence
  • Biomarkers
  • Epitopes*
  • Female
  • Genotype
  • Histocompatibility Antigens Class II / immunology*
  • Humans
  • Male
  • Molecular Probes / genetics
  • Molecular Sequence Data
  • Vasculitis / immunology*

Substances

  • Antibodies, Antineutrophil Cytoplasmic
  • Autoantibodies
  • Biomarkers
  • Epitopes
  • Histocompatibility Antigens Class II
  • Molecular Probes